Cytokine signature in chronic hepatitis C patients treated with peginterferon alpha 2A and ribavirin

被引：0
|
作者：
Neuman, M. G. [1 ,2 ,3 ]
Malkiewicz, I. M. [1 ]
Esguerra, R. [1 ,2 ,3 ]
Sha, K. [1 ,2 ,3 ,5 ]
Mazulli, T. [4 ,5 ]
Moussa, G. [4 ]
Morgan, M. [6 ,7 ]
Cohen, L. [6 ]
机构：
[1] MaRS, In Vitro Drug Safety & BioTechnol, Toronto, ON, Canada
[2] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada
[3] Univ Toronto, Inst Drug Res, Toronto, ON, Canada
[4] Mt Sinai Hosp, Dept Virol & Microbiol, Toronto, ON, Canada
[5] Univ Toronto, Dept Lab Med, Toronto, ON, Canada
[6] Sunnybrook Hlth Sci Ctr, Div Gastroenterol, Toronto, ON, Canada
[7] Univ Toronto, Dept Med, Toronto, ON, Canada
来源：
CLINICAL BIOCHEMISTRY | 2008年 / 41卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [21] Incidence of retinopathy in chronic Hepatitis C patients treated with pegylated interferon alpha 2a and ribavirin combination therapy
    Kashif, Muhammad
    Saleem, Muhammad Khurram
    Farooka, Imran Khan
    Husnain, Amino
    Siddiqui, Arif Mahmood
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2015, 31 (01) : 174 - 177
  • [22] Education by a Nurse Increases Response of Patients With Chronic Hepatitis C to Therapy With Peginterferon-α2a and Ribavirin
    Larrey, Dominique
    Salse, Annie
    Ribard, Didier
    Boutet, Olivier
    Hyrailles-Blanc, Valerie
    Niang, Birame
    Pageaux, Georges Philippe
    Vaucher, Emmanuel
    Arpurt, Jean Pierre
    Boulay, Guy
    Karlova, Natalia
    Daures, Jean Pierre
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (09) : 781 - 785
  • [23] Ketoprofen,peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C:A phaseⅡ study
    Annagiulia Gramenzi
    Carmela Cursaro
    Marzia Margotti
    Clara Balsano
    Alessandra Spaziani
    Simona Anticoli
    Elisabetta Loggi
    Maddalena Salerno
    Silvia Galli
    Giuliano Furlini
    Mauro Bernardi
    Pietro Andreone
    World Journal of Gastroenterology, 2009, 15 (47) : 5946 - 5952
  • [24] Peginterferon α-2a, Ribavirin and Fluvastatin Combination Therapy for Chronic Hepatitis C in Children and Adolescents
    Etani, Yuri
    Ida, Shinobu
    GASTROENTEROLOGY, 2011, 140 (05) : S456 - S457
  • [25] Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin
    Harrison, Stephen A.
    Hamzeh, Fayez M.
    Han, Jian
    Pandya, Prashant K.
    Sheikh, Muhammed Y.
    Vierling, John M.
    HEPATOLOGY, 2012, 56 (02) : 464 - 473
  • [26] Peginterferon and ribavirin for chronic hepatitis C
    Hoofnagle, Jay H.
    Seeff, Leonard B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23): : 2444 - 2451
  • [27] Analysis of early viral kinetics in chronic hepatitis C genotype 2 or 3 patients treated with peginterferon Alpha-2a and ribavirin
    Scherzer, Thomas-Matthias
    Staufer, Katharina
    Steindl-Munda, Petra
    Holzmann, Heidemarie
    Ferenci, Peter
    GASTROENTEROLOGY, 2007, 132 (04) : A789 - A789
  • [28] Cost-effectiveness of combination peginterferon α-2a and ribavirin compared with interferon α-2b and ribavirin in patients with chronic hepatitis C
    Sullivan, SD
    Jensen, M
    Bernstein, DE
    Hassanein, TI
    Foster, GR
    Lee, SS
    Cheinquer, H
    Craxi, A
    Cooksley, G
    Klaskala, W
    Pettit, K
    Patel, KK
    Green, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (08): : 1490 - 1496
  • [29] Peginterferon Alfa 2a/ribavirin versus Peginterferon Alfa 2b/ribavirin combination therapy in chronic Hepatitis C genotype 3
    Khan, Arif Q.
    Awan, Ali
    Shahbuddin, Sultan
    Igbal, Qamar
    GASTROENTEROLOGY, 2007, 132 (04) : A200 - A200
  • [30] ADVERSE REACTIONS TO THE COMBINED THERAPY OF PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C
    Faus Soler, Ma Teresa
    Zaragoza Marcet, Angela
    Escobar Cava, Paloma
    Tenias Burillo, Jost Ma
    Sangrador Garcia, Guillermo
    ATENCION FARMACEUTICA, 2009, 11 (02): : 110 - 116
12345